![]() 150000007523 nucleic acids Chemical group 0.000 claims description 35.150000001413 amino acids Chemical group 0.000 claims description 96.102000005614 monoclonal antibodies Human genes 0.000 claims abstract description 44.108010045030 monoclonal antibodies Proteins 0.000 claims abstract description 44.229920001850 Nucleic acid sequence Polymers 0.000 claims abstract description 62.210000004027 cells Anatomy 0.000 claims abstract description 93.241000282414 Homo sapiens Species 0.000 claims abstract description 172.108090001123 antibodies Proteins 0.000 title claims abstract description 410.102000004965 antibodies Human genes 0.000 title claims abstract description 410.Assignors: DEAN, YANN, ELSON, GREG, FISCHER, NICOLAS, KOSCO-VILBOIS, MARIE, LEGER, OLIVIER, MACH, BERNARD Publication of US20060177896A1 publication Critical patent/US20060177896A1/en Priority to US12/750,385 priority patent/US8551478B2/en Publication of US7728114B2 publication Critical patent/US7728114B2/en Application granted granted Critical Priority to US14/048,565 priority patent/US9850304B2/en Priority to US15/849,931 priority patent/US10759858B2/en Priority to US16/944,816 priority patent/US20210009691A1/en Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). ![]() Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US57648304P external-priority Priority to US11/145,131 priority Critical patent/US7728114B2/en Application filed by Novimmune SA filed Critical Novimmune SA Assigned to NOVIMMUNE S.A. Original Assignee Novimmune SA Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Bernard Mach Yann Dean Marie Kosco-Vilbois Greg Elson Nicolas Fischer Olivier Leger Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US11/145,131 Other versions US7728114B2 Google Patents US20060177896A1 - Anti-CD3 antibodies and methods of use thereof IT IS A VIOLATION PUNISHABLE UNDER LAW FOR ANY PERSON UNDER THE AGE OF TWENTY-ONE TO PRESENT ANY WRITTEN EVIDENCE OF AGE WHICH IS FALSE, FRAUDULENT OR NOT ACTUALLY HIS/HER OWN FOR THE PURPOSE OF ATTEMPTING TO PURCHASE ANY ALCOHOLIC BEVERAGE.US20060177896A1 - Anti-CD3 antibodies and methods of use thereof
0 Comments
Leave a Reply. |